The Mississippi Society of Oncology was formed in 1991 for the purpose ofpromoting the highest professional standards of oncology in Mississippi, to study, research and exchange information, experiences and ideas leading to improvement in oncology and promote educational opportunities.
In addition, the MOS is committed to support the search for more effective treatments of malignant diseases, work with other organizations and societies that have concerns with cancer care, and disseminate information regarding regulatory developments affecting members.
And finally the MOS acts as a resource for insurers regarding the standard of care in oncology and represents the practice of oncology and hematology in the State of Mississippi.
No one should have to fight Cancer alone. Join Amgen and six independent non-profit organizations that span the continuum of cancer care. The information and resources within these pages has been provided by the Breakaway from Cancer partners. Amgen has no control over these programs and provides information as a courtesy only.
Feb 23, 2020 - Physicians, Hospitals Meet Their New Competitor - Insurer-Owned Clinics, Find out more
Feb 18, 2020 - Insurance Companies Have No Place Practicing Medicine, Find out more
Feb 12, 2020 - Vapers Show Cancer-Associated Biological Changes Similar to Smokers,
Feb 4, 2020 - Oncologists Press Congress to Set 72-Hour Limit for Payers to Fill Cancer Drug Prescriptions, Find out more
Feb. 4, 2020 - Are Commercial Payers in Denial About Denials? Find out more
IMPORTANT INFORMATION FOR ALL PROVIDERS
FROM THE AMERICAN MEDICAL ASSOCIATION
As of January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services (CPT ® codes 99202-99215) for both new and established patients. Find out more
Improving Seniors’ Timely Access to Care Act of 2019
The Mississippi Society of Oncology is proud to have joined with hundreds of other health organizations to support the Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107) recently introduced by Reps. Suzan DelBene (D-WA), Mike Kelly (R-PA), Roger Marshall, MD (R-KS), and Ami Bera, MD (D-CA).
On February 18, 106 organizations representing patients, providers, medical researchers, survivors, and families joined together to urge Congress to include the bipartisan CLINICAL TREATMENT Act (H.R. 913) in the upcoming ‘must pass’ healthcare extenders package, which is expected to pass this spring. Find out more
Medicaid Block Grants Threaten Beneficiary Access to Cancer Care Find out more
Patient-Centered Oncology Payment Model Submitted to HHS Alternative Payment Model Advisory GroupFind out more
ASCO has partnered with the National Community Oncology Dispensing Association (NCODA)to create joint evidence-based standards for medically integrated in-office dispensing of oral anti-cancer drugs and supportive care medications.Find out More